Fri Sep 20 12:12:55 UTC 2024: ## Stryker Acquires NICO Corporation, Expanding its Neurosurgical Portfolio

**PORTAGE, Mich. –** Medical technology giant Stryker has announced the completion of its acquisition of NICO Corporation, a leading provider of minimally invasive neurosurgery devices. This strategic move will bolster Stryker’s neurotechnology portfolio, specifically in the areas of tumor resection and intracerebral hemorrhage (ICH) treatment.

ICH, a severe form of stroke caused by bleeding in the brain, affects over 3.4 million people annually worldwide. NICO’s BrainPath® and Myriad® systems offer less invasive treatment options for ICH, demonstrated to improve patient outcomes compared to traditional methods.

“The acquisition of NICO Corporation expands Stryker’s portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage, the deadliest form of stroke,” stated Andy Pierce, Stryker’s group president of MedSurg and Neurotechnology. “NICO’s products will enable Stryker to provide differentiated, minimally invasive approaches with the potential to significantly improve patient outcomes globally.”

This acquisition aligns with Stryker’s commitment to improving patient care, a mission reflected in its diverse range of medical products and services across multiple disciplines, including MedSurg, Neurotechnology, Orthopaedics, and Spine.

While the financial details of the transaction were not disclosed, investors are closely watching the impact of this move on Stryker’s financial performance. The company has demonstrated strong financial health in recent quarters, with 9% organic sales growth and a 10.6% increase in adjusted earnings per share in the second quarter of 2024. Analysts remain optimistic about Stryker’s future, citing its diverse product range and strategic acquisitions.

The acquisition of NICO Corporation is expected to solidify Stryker’s position as a leader in neurotechnology, with the potential to drive further growth and innovation in the field of minimally invasive neurosurgery.

Read More